Ascendis Pharma A/S (ASND)
213.99
+12.75
(+6.34%)
USD |
NASDAQ |
Dec 11, 15:37
Ascendis Pharma Market Cap: 13.07B for Dec. 11, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Evaxion AS | 40.77M |
| Novo Nordisk A/S | 222.80B |
| DBV Technologies SA | 528.08M |
| Cellectis SA | 527.71M |
| Biodexa Pharmaceuticals Plc | 4.095M |
Market Cap Related Metrics
| PS Ratio | 17.90 |
| Price | 213.99 |
| Earnings Yield | -1.98% |